Europe Genotyping Market Size, Share & Industry Trends Analysis Report By Product (Reagents & Kits, Instruments, and Software & Services), By Application, By End Use, By Technology, By Country and Growth Forecast, 2022 - 2028
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the Europe Genotyping Market
Market Report Description
The Europe Genotyping Market would witness market growth of 14.3% CAGR during the forecast period (2022-2028).
These cluster maps depict the origins of cases as well as the time frame in which they developed. This provides a considerably sharper picture of transmission dynamics, leading to better transmission control and prevention. All of these distinct types of genotyping are used in tandem to identify tuberculosis, stop it from spreading, and track down the source of infections. This has aided in the reduction of tuberculosis cases.
Genotyping by sequencing is one form that is utilized in agriculture to help with crop breeding. Single nucleotide polymorphisms (SNPs) are utilized as markers in this study, and RNA sequencing is used to examine gene expression in plants. This sort of genotyping provides information that can be used to improve agriculture by allowing for selective breeding of crops. Alfalfa's cell wall was strengthened through selective breeding, which was achieved through such genotyping. These methods have also led to the finding of genes that confer disease resistance. Wheat has a gene called Yr15 that protects it from a disease known as yellow wheat rust. Yellow wheat rust was therefore prevented via selective breeding for the Yr15 gene, which benefited agriculture.
The improved novel high-throughput nucleic acids analytical techniques in a variety of genetic and systems biology research that use well-phenotype materials, such as those from standardized European biobanks and animal institutions. Massively parallel sequencing technologies, for example, are critical components of modern biomedical research and are capable of revealing molecular and cellular processes underlying complex characteristics and disorders.
Since the genetic recombination, a valid and discriminate approach to genotype Cryptosporidium specimens at the cross-functional and cross-level necessitates the study of many loci, however, there is currently no standardized scheme available. In 2016, 23 scientists with specific skills in either Cryptosporidium genotyping and/or surveillance, epidemiology, or outbreaks met at the Robert Koch Institute in Berlin to discuss the processes for developing a robust, standards-compliant, multi-locus genotyping (MLG) scheme and posit an approach. Respondents selected mobility, biological robustness, type ability, and discriminating power as the most significant features in constructing a multilocus system in a rating exercise comprising performance and convenience criteria. For use with Cryptosporidium, a structured method for marker identification, assessment, verification, deployment, and maintenance was developed and defined, with a focus on Cryptosporidium parvum to help in the investigation of transmission in Europe.
The Germany market dominated the Europe Genotyping Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $2027.2 million by 2028. The UK market is exhibiting CAGR of 13.4% during (2022 - 2028). Additionally, The France market would witness a CAGR of 15.1% during (2022 - 2028).
Based on Product, the market is segmented into Reagents & Kits, Instruments, and Software & Services. Based on Application, the market is segmented into Diagnostics & Personalized Medicine, Agricultural Biotechnology, Pharmacogenomics, Animal Genetics, and Others. Based on End Use, the market is segmented into Diagnostics & Research Laboratories, Pharmaceutical & Biopharmaceutical Companies, Academic Institutes, and Others. Based on Technology, the market is segmented into PCR, Sequencing, Capillary Electrophoresis, Microarray, Mass Spectrometry, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Genotyping Market will Hit $30.9 Billion by 2028, at a CAGR of 14.7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include F. Hoffmann-La Roche Ltd., Danaher Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., Illumina, Inc., Bio-Rad Laboratories, Inc., Eurofins Scientific Group, and Fluidigm Corporation.
Scope of the Study
Market Segments Covered in the Report:
- Reagents & Kits
- Software & Services
- Reagents & Kits
- Software & Services
By End Use
- Diagnostics & Research Laboratories
- Pharmaceutical & Biopharmaceutical Companies
- Academic Institutes
- Capillary Electrophoresis
- Mass Spectrometry
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation
- Agilent Technologies, Inc.
- Thermo Fisher Scientific, Inc.
- Qiagen N.V.
- Illumina, Inc.
- Bio-Rad Laboratories, Inc.
- Eurofins Scientific Group
- Fluidigm Corporation
Unique Offerings from KBV Research
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free